1. Home
  2. TLSI vs RIV Comparison

TLSI vs RIV Comparison

Compare TLSI & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.92

Market Cap

272.3M

Sector

Health Care

ML Signal

HOLD

Logo RiverNorth Opportunities Fund Inc.

RIV

RiverNorth Opportunities Fund Inc.

HOLD

Current Price

$11.88

Market Cap

329.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSI
RIV
Founded
2010
2015
Country
United States
United States
Employees
110
N/A
Industry
Medical Specialities
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
272.3M
329.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TLSI
RIV
Price
$4.92
$11.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
151.1K
87.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
12.85%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$55.47
N/A
Revenue Next Year
$40.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.42
$10.11
52 Week High
$7.95
$12.56

Technical Indicators

Market Signals
Indicator
TLSI
RIV
Relative Strength Index (RSI) 46.92 41.65
Support Level $4.90 $11.57
Resistance Level $5.50 $11.93
Average True Range (ATR) 0.33 0.10
MACD 0.05 -0.02
Stochastic Oscillator 46.30 36.35

Price Performance

Historical Comparison
TLSI
RIV

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

Share on Social Networks: